LEAH ATKINSON: Open Payments
NPI 1043548357 · CHARLESTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$799 in 42 payments from 10 companies in 2025. Trend: 2023 $498 · 2024 $749 · 2025 $799
Food & beverage: $700Education: $99
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 9 | $259 |
| Novartis Pharmaceuticals Corporation | 14 | $163 |
| Celgene Corporation | 12 | $148 |
| Incyte Corporation | 1 | $99 |
| Astellas Pharma US Inc | 1 | $33 |
| PFIZER INC. | 1 | $24 |
| Tempus AI, Inc | 1 | $21 |
| ABBVIE INC. | 1 | $20 |
| Gilead Sciences, Inc. | 1 | $19 |
| Janssen Biotech, Inc. | 1 | $14 |
Products named: REBLOZYL, KISQALI, OPDIVO, OPDUALAG, Xtandi, IBRANCE, SCEMBLIX, XT CDX.
Industry payments across WV — which companies pay providers there.
